Trial Profile
Specific post-marketing surveillance of Geninax(R) Tablets 200 mg Efficacy and safety against bacterial pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Garenoxacin (Primary)
- Indications Pneumonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Toyama Chemical
- 30 Oct 2013 New trial record